KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Current Taxes (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Current Taxes for 17 consecutive years, with $36.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Taxes rose 17.31% to $36.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.6 million, a 17.31% increase, with the full-year FY2025 number at $36.6 million, up 17.31% from a year prior.
  • Current Taxes was $36.6 million for Q4 2025 at Bio-Rad Laboratories, down from $44.8 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $104.0 million in Q3 2023 to a low of $10.3 million in Q4 2021.
  • A 5-year average of $44.1 million and a median of $36.6 million in 2025 define the central range for Current Taxes.
  • Peak YoY movement for Current Taxes: skyrocketed 255.19% in 2023, then plummeted 58.04% in 2024.
  • Bio-Rad Laboratories' Current Taxes stood at $10.3 million in 2021, then skyrocketed by 214.26% to $32.4 million in 2022, then grew by 10.4% to $35.8 million in 2023, then fell by 12.85% to $31.2 million in 2024, then rose by 17.31% to $36.6 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Current Taxes are $36.6 million (Q4 2025), $44.8 million (Q3 2025), and $36.2 million (Q2 2025).